Waldenstrom Macroglobulinemia1 | Smoldering Waldenstrom Macro globulinemia1 | IgM MGUS1 | Multiple Myeloma | Marginal Zone Lymphoma |
---|---|---|---|---|
1. IgM monoclonal gammopathy of any concentration. 2. BM infiltration by small lymphocytes with plasmacytoid or plasma cell differentiation≥10% 3. Intertrabecular patterns of BM infiltration. 4. Surface marker - Positive: IgM, CD19, CD20, CD22, CD25, CD27, FMC7 - Negative: CD10, CD23, CD103, CD138 5. Presence of symptoms |
1. Meet the criterial of WM 2. Absence of symptoms, anemia, organomegaly, lymphadenopathy, or hyperviscosity |
1. Serum IgM monoclonal protein <3000mg/L 2. BM lymphoplasmacytic infiltration <10% 3. No evidence of end-organ damage, anemia, hyperviscosity, lymphoadenopathy, or hepatosplenomegaly from the underlying lymphoproliferative disorder. |
1. Clonal BM plasma cell ≥ 10% or biopsy proven plasmacytoma and at least one of the myeloma defining events - Hypercalcemia with serum Ca >0.25mmol/L higher than the upper normal limit or >2.75mmol/L - Renal impairment with CrCl < 40ml/min or serum Cr > 2mg/dL - Anemia with Hb <100g/L or more than 20g/L below than lower normal limit - Osteolytic bone lesions on skeletal radiography, CT, or PET/CT |
1. Polymophous small cell infiltration with associated reactive appearing follicles. 2. Positive for B-cell markers including CD19, CD20, CD22. 3. Negative for CD5, CD10, and CD23. 4. Presence of trisomy3 or t(11;18) |